Reiterative Development and Evaluation Study of OSA Therapy System
NCT ID: NCT01634074
Last Updated: 2013-11-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
150 participants
OBSERVATIONAL
2012-07-31
2014-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
OSA patients
Patients with Obstructive Sleep Apnea (OSA), or suspected OSA
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Subject is fluent in English and understands the Study protocol and is willing and able to comply with Study requirements and sign the informed consent form.
3. Subject has a least one molar in each of the four quadrants of the mouth (right upper, right lower, left upper, and left lower).
Exclusion Criteria
2. Oral cavity infection or any other oral or dental condition or problem that would limit subject use of the ApniCure System (e.g. dentures, loose tooth/teeth, temporomandibular joint (TMJ) conditions, or any oral or dental condition that the Investigator believes could be exacerbated by the Attune Sleep Apnea System.
3. History of any OSA surgical treatment including uvulopalatopharyngoplasty surgery (UPPP), maxillomandibular advancement surgery (MMA), radio frequency (RF) ablation treatment, palatal stent devices, etc.
4. Any concomitant diagnosed or suspected sleep or chronic neurological disorders, other than OSA, including insomnia, and central sleep apnea.
5. Currently working nights, or rotating night shifts.
6. Current disease state, use of medication or other treatment which, in the investigator's opinion, may pose additional risk to the subject or confound the results of the study.
7. Female subjects of child bearing age who are pregnant or intend to become pregnant during the study period.
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ApniCure, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mehran Farid-Moayer, MD
Role: PRINCIPAL_INVESTIGATOR
Peninsula Sleep lab
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Penninsula Sleep Center (PSC)
Burlingame, California, United States
ApniCure, Inc.
Redwood City, California, United States
Sleep Disorders Center of Georgia (SDCG)
Atlanta, Georgia, United States
Kentucky Research Group
Louisville, Kentucky, United States
The Center for Sleep & Wake Disorders
Chevy Chase, Maryland, United States
SleepMed
Columbia, South Carolina, United States
Sleep Medicine Associates of Texas (SMAT)
Dallas, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Mehran Farid-Moayer, MD
Role: primary
Andrea L Brown, M.S.
Role: primary
Alan Lankford, PhD
Role: primary
Pamela A McCullough, PhD, APRN, CCRC
Role: primary
Jaime Stiles
Role: primary
Richard Bogan, MD
Role: primary
Philip Becker, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11847
Identifier Type: -
Identifier Source: org_study_id